同行扩大参与刺激剂危害降低与应急管理研究:一个协议文件
Alexis Cooke1, Erin Stack2, Linda Peng3
1Comagine Health, 650 NE Holladay Street, Portland, OR, 97232, USA. acooke@comagine.org.
Addiction science & clinical practice
|June 10, 2025
概括
同龄人恢复支持专家正在测试应急管理 (CM),以激励不寻求治疗的兴奋剂使用者减少伤害的目标. 这项研究评估了CMCM.
科学领域:
- 公共卫生 公共卫生
- 成 药物 药物 药物 药物
- 实施科学 实施科学
背景情况:
- 由同行恢复支持专家提供的应急管理 (CM),激励那些不寻求治疗的兴奋剂使用者减少伤害的目标,此前没有研究过.
- 同行扩大参与刺激剂危害减少与应急管理 (PEER-CM) 的研究比较了两种同行促进的CM干预措施:一个是激励客户识别的减少危害目标,另一个是激励同行访问出席.
研究的目的:
- 为了比较两个同行辅助的CM干预措施对使用兴奋剂而没有寻求正式治疗的个体的有效性.
- 评估减少阿片类药物过量服用和兴奋剂过度放大的主要结果.
- 评估二次结果,包括实现客户确定的减伤目标和参与物质使用障碍治疗.
主要方法:
- 在俄勒冈州的14个基于社区的同行服务站点中采用了混合型1有效性实施框架和阶梯式形设计.
- 同行专家经过培训来提供CM,所有网站都实施了标准CM,用于同行访问出席.
- 每两个月,在两个地点随机引入一个实验性的CM条件,激励客户导向的减少危害活动. 同行监测进度和管理激励措施,促进客户实现目标.
主要成果:
- 主要研究结果是同行报告的致命过量服用或首次参与者报告的非致命过量服用或过度放大 (急性兴奋剂毒性) 的时间.
- 二次结果包括实现客户确定的减伤目标和参与物质使用障碍治疗.
- 可行性将通过通过指导到标准的过程证明同行对CM技能的熟练程度,并通过定性面试来补充.
结论:
- 该PEER-CM试验是研究同行促进的CM的先驱,旨在减少非寻求治疗的兴奋剂使用者的危害和过量减少.
- 预计这些发现将为同行促进的CM交付及其应用于以客户为中心的减少危害目标提供关键证据.
相关概念视频
Stimulants
167
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
167
Attention-Deficit/Hyperactivity Disorder
50
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
50


